Cite
Kondo C, Atsukawa M, Tsubota A, et al. Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease. Hepatol Res. 2017;47(11):1165-1173doi: 10.1111/hepr.12879.
Kondo, C., Atsukawa, M., Tsubota, A., Shimada, N., Abe, H., Asano, T., Yoshizawa, K., Okubo, T., Chuganji, Y., Aizawa, Y., Iio, E., Tanaka, Y., & Iwakiri, K. (2017). Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease. Hepatology research : the official journal of the Japan Society of Hepatology, 47(11), 1165-1173. https://doi.org/10.1111/hepr.12879
Kondo, Chisa, et al. "Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,11 (2017): 1165-1173. doi: https://doi.org/10.1111/hepr.12879
Kondo C, Atsukawa M, Tsubota A, Shimada N, Abe H, Asano T, Yoshizawa K, Okubo T, Chuganji Y, Aizawa Y, Iio E, Tanaka Y, Iwakiri K. Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease. Hepatol Res. 2017 Oct;47(11):1165-1173. doi: 10.1111/hepr.12879. Epub 2017 Apr 12. PMID: 28225572.
Copy
Download .nbib